107 related articles for article (PubMed ID: 3169091)
21. The role of US and MR imaging in detecting local chest wall tumor recurrence after mastectomy.
Yilmaz MH; Esen G; Ayarcan Y; Aydoğan F; Ozgüroğlu M; Demir G; Beşe N; Mandel NM
Diagn Interv Radiol; 2007 Mar; 13(1):13-8. PubMed ID: 17354188
[TBL] [Abstract][Full Text] [Related]
22. Validation of the SCM-test for the diagnosis of cancer.
Deutsch M; Weinreb A
Eur J Cancer Clin Oncol; 1983 Feb; 19(2):187-93. PubMed ID: 6681765
[TBL] [Abstract][Full Text] [Related]
23. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
Caliskan M; Gatti G; Sosnovskikh I; Rotmensz N; Botteri E; Musmeci S; Rosali dos Santos G; Viale G; Luini A
Breast Cancer Res Treat; 2008 Dec; 112(3):513-21. PubMed ID: 18240020
[TBL] [Abstract][Full Text] [Related]
24. Factors affecting the palpability of breast lesion by self-examination.
Lam WW; Chan CP; Chan CF; Mak CC; Chan CF; Chong KW; Leung MH; Tang MH
Singapore Med J; 2008 Mar; 49(3):228-32. PubMed ID: 18363005
[TBL] [Abstract][Full Text] [Related]
25. Bilateral and multifocal breast carcinoma. A clinical and autopsy study with special emphasis on carcinoma in situ.
Ringberg A; Palmer B; Linell F; Rychterova V; Ljungberg O
Eur J Surg Oncol; 1991 Feb; 17(1):20-9. PubMed ID: 1847343
[TBL] [Abstract][Full Text] [Related]
26. Response of T lymphocytes to phytohaemagglutinin (PHA) and to cancer-tissue-associated antigens, measured by the intracellular fluorescence polarization technique (SCM test).
Orjasaeter H; Jordfald G; Svendsen I
Br J Cancer; 1979 Oct; 40(4):628-33. PubMed ID: 387060
[TBL] [Abstract][Full Text] [Related]
27. [Non palpable lesions of the breast: the Mammotome-biopsy in the preoperative management of breast cancer].
Ceccarelli G; Casciola L; Battistini I; Stefanoni M; Spaziani A; Conti D; Di Zitti L; Valeri R; Bartoli A; Bellochi R; Rambotti M; Pisanelli MC
G Chir; 2005 May; 26(5):187-93. PubMed ID: 16184700
[TBL] [Abstract][Full Text] [Related]
28. Effects of osmomolarity, calcium and magnesium ions on the structuredness of cytoplasmic matrix (SCM).
Cercek L; Cercek B
Radiat Environ Biophys; 1976 Mar; 13(1):9-12. PubMed ID: 959479
[TBL] [Abstract][Full Text] [Related]
29. The SCM test for cancer. an evaluation in terms of lymphocytes from healthy donors and cancer patients.
Mitchell H; Wood P; Pentycross CR; Abel E; Bagshawe KD
Br J Cancer; 1980 May; 41(5):772-7. PubMed ID: 6158967
[TBL] [Abstract][Full Text] [Related]
30. Inhibitors of haemopoietic cell proliferation? Specificity of action within the haemopoietic system.
Lord BI; Cercek L; Cercek B; Shah GP; Dexter TM; Lajtha LG
Br J Cancer; 1974 Feb; 29(2):168-75. PubMed ID: 4857338
[TBL] [Abstract][Full Text] [Related]
31. Not all false positive diagnoses are equal: On the prognostic implications of false-positive diagnoses made in breast MRI versus in mammography / digital tomosynthesis screening.
Kuhl CK; Keulers A; Strobel K; Schneider H; Gaisa N; Schrading S
Breast Cancer Res; 2018 Feb; 20(1):13. PubMed ID: 29426360
[TBL] [Abstract][Full Text] [Related]
32. MRI before reexcision surgery in patients with breast cancer.
Lee JM; Orel SG; Czerniecki BJ; Solin LJ; Schnall MD
AJR Am J Roentgenol; 2004 Feb; 182(2):473-80. PubMed ID: 14736685
[TBL] [Abstract][Full Text] [Related]
33. Lesions of "uncertain malignant potential" in the breast (B3) identified with mammography screening.
Richter-Ehrenstein C; Maak K; Röger S; Ehrenstein T
BMC Cancer; 2018 Aug; 18(1):829. PubMed ID: 30115017
[TBL] [Abstract][Full Text] [Related]
34. The clinical impact of breast scintigraphy acquired with a breast specific γ-camera (BSGC) in the diagnosis of breast cancer: incremental value versus mammography.
Spanu A; Sanna D; Chessa F; Manca A; Cottu P; Fancellu A; Nuvoli S; Madeddu G
Int J Oncol; 2012 Aug; 41(2):483-9. PubMed ID: 22641247
[TBL] [Abstract][Full Text] [Related]
35. Potential for anatomic localization in colorectal cancer using the SCM test.
Merimsky O; Deutsch M; Ron I; Tirosh R; Dale A; Weinreb A; Chaitchik S
Oncol Rep; 1996 Nov; 3(6):1141-3. PubMed ID: 21594526
[TBL] [Abstract][Full Text] [Related]
36. A flow system adaptation of the SCM test for detection of lymphocyte response in patients with recurrent breast cancer.
Stewart S; Pritchard KI; Meakin JW; Price GB
Clin Immunol Immunopathol; 1979 Jun; 13(2):171-81. PubMed ID: 156612
[No Abstract] [Full Text] [Related]
37. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions.
Bibbo M; Scheiber M; Cajulis R; Keebler CM; Wied GL; Dowlatshahi K
Acta Cytol; 1988; 32(2):193-201. PubMed ID: 2831687
[TBL] [Abstract][Full Text] [Related]
38. An analysis of the SCM test in cancer diagnosis.
Cercek B
Cancer; 1984 Jun; 53(12):17A-18A. PubMed ID: 6722719
[No Abstract] [Full Text] [Related]
39. Lumpectomy cavity shaved margins do not impact re-excision rates in breast cancer patients.
Coopey SB; Buckley JM; Smith BL; Hughes KS; Gadd MA; Specht MC
Ann Surg Oncol; 2011 Oct; 18(11):3036-40. PubMed ID: 21947583
[TBL] [Abstract][Full Text] [Related]
40. Application of the phenomenon of changes in the structuredness of cytoplasmic matrix (SCM) in the diagnosis of malignant disorders: a review.
Cercek L; Cercek B
Eur J Cancer (1965); 1977 Sep; 13(9):903-15. PubMed ID: 334557
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
